JP2023526311A5 - - Google Patents
Info
- Publication number
- JP2023526311A5 JP2023526311A5 JP2022569267A JP2022569267A JP2023526311A5 JP 2023526311 A5 JP2023526311 A5 JP 2023526311A5 JP 2022569267 A JP2022569267 A JP 2022569267A JP 2022569267 A JP2022569267 A JP 2022569267A JP 2023526311 A5 JP2023526311 A5 JP 2023526311A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- patient
- brain mass
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023459P | 2020-05-12 | 2020-05-12 | |
| US63/023,459 | 2020-05-12 | ||
| US202063070653P | 2020-08-26 | 2020-08-26 | |
| US63/070,653 | 2020-08-26 | ||
| US202063073756P | 2020-09-02 | 2020-09-02 | |
| US63/073,756 | 2020-09-02 | ||
| PCT/US2021/031802 WO2021231443A1 (en) | 2020-05-12 | 2021-05-11 | Compositions useful in treatment of krabbe disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023526311A JP2023526311A (ja) | 2023-06-21 |
| JP2023526311A5 true JP2023526311A5 (cg-RX-API-DMAC7.html) | 2024-05-22 |
| JP7832898B2 JP7832898B2 (ja) | 2026-03-18 |
Family
ID=76284168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569267A Active JP7832898B2 (ja) | 2020-05-12 | 2021-05-11 | クラッベ病の治療に有用な組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230210941A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4149564A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7832898B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230023637A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116057175A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021271635A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022021786A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3177924A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2022017953A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298137A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022014245A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021231443A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1967872A (en) | 1930-07-14 | 1934-07-24 | Gilbert E Doan | Welding electrode |
| JP2002521107A (ja) | 1998-07-23 | 2002-07-16 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 高解像度画像センサを備えたx線検査装置 |
| US6596535B1 (en) | 1999-08-09 | 2003-07-22 | Targeted Genetics Corporation | Metabolically activated recombinant viral vectors and methods for the preparation and use |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| US8005620B2 (en) | 2003-08-01 | 2011-08-23 | Dna Twopointo Inc. | Systems and methods for biopolymer engineering |
| WO2005012877A2 (en) | 2003-08-01 | 2005-02-10 | Dna Twopointo Inc. | Systems and methods for antibody engineering |
| EP1668143B1 (en) | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| DE23193606T1 (de) | 2005-04-07 | 2024-02-15 | The Trustees Of The University Of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
| JP4495210B2 (ja) | 2005-06-09 | 2010-06-30 | パナソニック株式会社 | 振幅誤差補償装置及び直交度誤差補償装置 |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| WO2011126808A2 (en) | 2010-03-29 | 2011-10-13 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| EP2588132A4 (en) * | 2010-06-25 | 2014-10-15 | Shire Human Genetic Therapies | METHOD AND COMPOSITIONS FOR DELIVERING BETA GALACTOCEREBROSIDASE INTO THE CNS |
| FR2977562B1 (fr) | 2011-07-06 | 2016-12-23 | Gaztransport Et Technigaz | Cuve etanche et thermiquement isolante integree dans une structure porteuse |
| US9719106B2 (en) * | 2013-04-29 | 2017-08-01 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof |
| WO2016049230A1 (en) | 2014-09-24 | 2016-03-31 | City Of Hope | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof |
| IL262207B2 (en) | 2016-04-15 | 2026-01-01 | Univ Pennsylvania | Preparations for the treatment of wet age-related macular degeneration |
| JP2020505317A (ja) | 2017-01-20 | 2020-02-20 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 臍帯血移植(ucbt)および増加したガラクトセレブロシダーゼの発現によるクラッベ病の処置 |
| RS65241B1 (sr) | 2017-02-28 | 2024-03-29 | Univ Pennsylvania | Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe |
| WO2018160852A1 (en) | 2017-03-03 | 2018-09-07 | Cook Medical Technologies, LLC | Rapid exchange multiple catheter system |
| EP3692158A4 (en) * | 2017-10-03 | 2021-08-04 | Prevail Therapeutics, Inc. | GENE THERAPIES FOR LYSOSOMAL DISEASES |
| EP3860714B1 (en) | 2018-10-03 | 2023-09-06 | Siteone Therapeutics, Inc. | 11,13-modified saxitoxins for the treatment of pain |
| EP3931337A1 (en) * | 2019-02-26 | 2022-01-05 | The Trustees of The University of Pennsylvania | Compositions useful in treatment of krabbe disease |
-
2021
- 2021-05-11 AU AU2021271635A patent/AU2021271635A1/en active Pending
- 2021-05-11 US US17/998,330 patent/US20230210941A1/en active Pending
- 2021-05-11 BR BR112022021786A patent/BR112022021786A2/pt unknown
- 2021-05-11 WO PCT/US2021/031802 patent/WO2021231443A1/en not_active Ceased
- 2021-05-11 JP JP2022569267A patent/JP7832898B2/ja active Active
- 2021-05-11 CA CA3177924A patent/CA3177924A1/en active Pending
- 2021-05-11 CN CN202180049138.9A patent/CN116057175A/zh active Pending
- 2021-05-11 IL IL298137A patent/IL298137A/en unknown
- 2021-05-11 MX MX2022014245A patent/MX2022014245A/es unknown
- 2021-05-11 KR KR1020227042731A patent/KR20230023637A/ko active Pending
- 2021-05-11 EP EP21730355.1A patent/EP4149564A1/en active Pending
-
2022
- 2022-12-12 CO CONC2022/0017953A patent/CO2022017953A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7860176B2 (ja) | 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法 | |
| TWI832036B (zh) | 用於aav之遞送之組合物及方法 | |
| US20220175887A1 (en) | Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus | |
| JP2021500029A (ja) | Nt−3遺伝子治療のための方法及び材料 | |
| JP2025060641A (ja) | Aavウイルスベクター及びその使用 | |
| JP2022511776A5 (cg-RX-API-DMAC7.html) | ||
| JP2021523198A5 (cg-RX-API-DMAC7.html) | ||
| TW201629225A (zh) | 第九因子基因療法 | |
| JP2023540054A5 (cg-RX-API-DMAC7.html) | ||
| CN110325219B (zh) | 编码甲基-CpG结合蛋白2的重组腺相关病毒的鞘内递送 | |
| JP2022523766A5 (cg-RX-API-DMAC7.html) | ||
| JP2022512589A5 (cg-RX-API-DMAC7.html) | ||
| JP2025506383A5 (cg-RX-API-DMAC7.html) | ||
| JP2021534154A5 (cg-RX-API-DMAC7.html) | ||
| US20200318080A1 (en) | Methods and compositions for treating equine conditions using recombinant self-complementary adeno-associated virus | |
| CA3178591A1 (en) | Immunosuppressive agents and viral delivery re-dosing methods for gene therapy | |
| CN119255814A (zh) | 脑中bag3和蛋白质的质量控制 | |
| JP2023513487A5 (cg-RX-API-DMAC7.html) | ||
| JP2022525848A5 (cg-RX-API-DMAC7.html) | ||
| AU2022325237A2 (en) | Retrograde coronary venous or sinus administration of therapeutics | |
| JP2022550954A5 (cg-RX-API-DMAC7.html) | ||
| JP2022518354A5 (cg-RX-API-DMAC7.html) | ||
| JP2022522004A (ja) | 依存症障害の遺伝子治療 | |
| RU2796274C2 (ru) | Вирусные векторы на основе aav и пути их применения | |
| HK40121244A (en) | Methods and materials for nt-3 gene therapy |